AVE - Aventis $78.71 (+1.86)

This maker of specialty chemicals and pharmaceuticals for the healthcare industry has never split its shares. However, given the fact that it is trading over $75/share, we feel it is time for the ADR to announce a split. It has unlimited shares authorized, so a 2:1 may definitely be in the cards. We will keep our eyes and ears open for a BoD meeting towards the end of next quarter.

SRDX - SurModics, Inc. $42.56 (+6.56)

SRDX also is a chemical maker for the healthcare industry. The stock last split 2:1 back in December of 2000 at $49/share. We are now closing in on SRDX's historical split range and with 45 million shares authorized and only 16 million outstanding; SRDX could definitely do a 2:1. We will look towards SRDX's earnings release date of 4/17 as the next likely time for a split announcement.